Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Junhan Jiang"'
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Ovarian function suppression (OFS) is indicated in premenopausal women with early or metastasis breast cancer, which may be achieved with similar effect by gonadotropin-releasing hormone agonists (GnRHa) or ovarian ablation (OA).
Externí odkaz:
https://doaj.org/article/a2b8309d9c6841e5a290b43da5d491a7
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
PurposeThis study aimed to assess the efficacy of utidelone, a novel genetically engineered epothilone analog, combined with capecitabine in our center and, furthermore, to identify whether ganglioside monosialic acid (GM1) improved chemotherapy-indu
Externí odkaz:
https://doaj.org/article/e6b3b20fa5674f50a93201fcb908e534
Autor:
Sen Qiu, Tianqi Fan, Junhan Jiang, Zhelong Wang, Yongzhen Wang, Junnan Xu, Tao Sun, Nan Jiang
Publikováno v:
Information Sciences. 633:264-279
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5e393fcade307b4b179661e52f083d
https://doi.org/10.1016/j.ins.2023.03.058
https://doi.org/10.1016/j.ins.2023.03.058
Autor:
Tianqi Fan, Sen Qiu, Zhelong Wang, Hongyu Zhao, Junhan Jiang, Yongzhen Wang, Junnan Xu, Tao Sun, Nan Jiang
Publikováno v:
Computers in Biology and Medicine. 159:106938
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6ea17e832f7750f167c246b54bae04
https://doi.org/10.1016/j.compbiomed.2023.106938
https://doi.org/10.1016/j.compbiomed.2023.106938
Publikováno v:
OncoTargets and Therapy. 13:4971-4985
Background Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. Previous investigation suggested Aurora A kinase was able to partially r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb224e813d8e604be8d8453182c6985f
https://doi.org/10.2147/ott.s250619
https://doi.org/10.2147/ott.s250619
Purpose: We examined whether there were differences in major depression outcomes and independent risk factors associated with gonadotropin-releasing hormone agonists (GnRHa) and ovarian ablation (OA) in premenopausal breast cancer patients. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b690bcc5f7ccbc5749b8442c8f90cf3
https://doi.org/10.21203/rs.3.rs-284329/v1
https://doi.org/10.21203/rs.3.rs-284329/v1
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Background: In BG01-1323L trial, utidelone, a novel genetically engineered epothilone analogue, combined with capecitabine improved progression-free survival and overall survival in heavily pretreated metastatic breast cancer prior to anthracycline a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edb2e8fb16503f27d21844fa92cc06b
https://doi.org/10.3389/fonc.2020.524223
https://doi.org/10.3389/fonc.2020.524223
Background: Ovarian function suppression is being widely utilized as endocrine therapy to reduce estrogen release in premenopausal breast cancer patients and was achieved either by medical treatment with bilateral oophorectomy, irradiation, or the Go
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88b02d437fa4d041a2f411566ae1d1b0
https://doi.org/10.21203/rs.3.rs-66195/v1
https://doi.org/10.21203/rs.3.rs-66195/v1
Publikováno v:
OncoTargets and therapy
Background Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. Previous investigation suggested Aurora A kinase was able to partially r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d5a10a59add5c870f4a8310273f8057
https://pubmed.ncbi.nlm.nih.gov/32581556
https://pubmed.ncbi.nlm.nih.gov/32581556